Drugmaker to sell cheaper generic rival to EpiPen injectors

This image provided by Sandoz Inc. shows a new epinephrine injector by Sandoz, Inc. Amid persistent shortages of EpiPens and other emergency autoinjectors that treat life-threatening allergic reactions, generic drugmaker Sandoz says that early next year it will launch a slightly cheaper rival in the U.S. Sandoz said Thursday, Dec. 6, 2018, that it plans to sell a pair of its generic autoinjectors for $250 without insurance. Photo: Sandoz Inc. via AP
This image provided by Sandoz Inc. shows a new epinephrine injector by Sandoz, Inc. Amid persistent shortages of EpiPens and other emergency autoinjectors that treat life-threatening allergic reactions, generic drugmaker Sandoz says that early next year it will launch a slightly cheaper rival in the U.S. Sandoz said Thursday, Dec. 6, 2018, that it plans to sell a pair of its generic autoinjectors for $250 without insurance.

December 06, 2018 05:48 PM

Generic drug-maker Sandoz announced plans Thursday to start selling a slightly cheaper version of the EpiPen in the U.S. early next year.

The pen-like injectors are used to halt life-threatening allergic reactions to insect bites, nuts and other foods. Brand-name EpiPen, which dominates the market, has been in short supply since spring because of production problems.

Advertisement

RELATED: US approves new generic competitor to EpiPen 

Sandoz will sell a pair of injectors, under the name Symjepi, for $250 without insurance. Two other generics on the market in the U.S. cost $300 a pair, including one from EpiPen seller Mylan. The company started selling its own generic after it was blasted for repeated hikes that pushed up its list price from $94 to $608 for a pair of brand-name EpiPens.

What people pay varies, though, depending on insurance, discounts and the pharmacy.

Mylan's injectors are made by a subsidiary of Pfizer, which is upgrading factories to fix quality problems. That resulted in production slowdowns. Pfizer said Thursday it's shipping some injectors and expects to ship more in the coming months.


More from KSTP:


The shortages triggered temporary shortages of other injectors, including Auvi-Q. As a result, U.S. regulators let some manufacturers extend expiration dates.

Sandox, part of Novartis AG., will sell adult injectors made by Adamis Pharmaceuticals Corp. A children's version will follow.

Israel's Teva Pharmaceutical Industries began selling limited quantities of its new generic EpiPen in the U.S. last week.

Connect with KSTP


Join the conversation on our social media platforms. Share your comments on our Facebook, Instagram, and Twitter pages.

Credits

The Associated Press

(Copyright 2018 by The Associated Press. All Rights Reserved.)

Advertisement

Two U of M Gopher wrestlers being held on suspicion of criminal sexual conduct

UPDATE: Body found in Lake George as part of search and recovery

Frazee father drowns saving child who fell from bridge in Detroit Lakes

Target cash registers back online after nationwide outage

Navy unveils new ship named after Twin Cities

Advertisement